REDWOOD CITY, Calif., Jan. 29, 2025 /Business Wire/ — EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of CRISPR gene editing. By leveraging a groundbreaking guide RNA (gRNA) design strategy, XDel technology ensures robust, reliable, and reproducible gene knockout results that accelerate research in functional genomics, disease modeling, and drug development.
The introduction of XDel Knockout Cells is a strategic extension of EditCo’s comprehensive Engineered Cell portfolio. It further solidifies the company’s position as a leader in cell engineering solutions that includes precision knockout and knock-in technologies across cell types, including immortalized, iPS, and primary cell lines like T cells and fibroblasts.
Read the full article on businesswire.com
Share this page on social
Get the latest tips, tricks, and news
Get the latest tips, tricks, and news
Copyright © 2024 Samba Scientific. All rights reserved.
sambaHBSPTformCreate({portalId:"4491905",
formId:"c73f88f8-199b-4af7-b9f2-ebf3896649a9"
});